Labeler
Pfizer Laboratories Div Pfizer Inc NDC Codes
Pfizer Laboratories Div Pfizer Inc lists 236 finished drug products in the FDA NDC Directory under NDC labeler codes 0013, 0025, 0069, 60793, 72618.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Doxorubicin Hydrochloride, Octagam Immune Globulin (Human), Caduet, Talzenna, Cutaquig, Paxlovid, Comirnaty, Hympavzi, Abrilada, Xalkori, Cibinqo, Propofol, Ibrance, Thrombin-Jmi, Bosulif
- Active ingredients
- Human immunoglobulin g, Doxorubicin hydrochloride, Amlodipine besylate, Atorvastatin calcium trihydrate, Talazoparib tosylate, Marstacimab, Crizotinib, Abrocitinib, Propofol, Palbociclib, Thrombin, Bnt-162b2 omicron (Xfg) mrna
- NDC labeler codes
- 0013, 0025, 0069, 60793, 72618
- Strengths (from the 100 most recently listed products)
- Doxorubicin hydrochloride 2 mg/mL; Human immunoglobulin g 100 mg/mL; Human immunoglobulin g 165 mg/mL; Human immunoglobulin g 50 mg/mL; Amlodipine besylate 5 mg/1; Amlodipine besylate 10 mg/1; Propofol 10 mg/mL; Marstacimab 150 mg/mL; Talazoparib tosylate .5 mg/1; Atorvastatin calcium trihydrate 80 mg/1; Atorvastatin calcium trihydrate 20 mg/1; Atorvastatin calcium trihydrate 40 mg/1; Atorvastatin calcium trihydrate 10 mg/1; Rimegepant sulfate 75 mg/1; Thrombin 5000 [iU]/5mL; Bnt-162b2 omicron (Xfg) mrna .0158 mg/.48mL; Bnt-162b2 omicron (Xfg) mrna .042 mg/.418mL; Marstacimab 75 mg/.5mL; Thrombin 20000 [iU]/20mL; Leucovorin calcium 5 mg/1
- Dosage forms
- Injection, Solution, Solution, Tablet, Film coated, Kit, Capsule, Liquid filled, Injection, Suspension, Capsule, Capsule, Coated pellets, Injection, Injection, Emulsion, Liquid, Injection, Powder, Lyophilized, For solution, Tablet, Orally disintegrating, Tablet, System, Spray, Tablet, Film coated, Extended release
- Routes
- Oral, Intravenous, Subcutaneous, Intramuscular, Topical, Vaginal, Nasal
- Drug classes (FDA established)
- Human Immunoglobulin G, Anthracycline Topoisomerase Inhibitor, Kinase Inhibitor, Calcium Channel Blocker, Dihydropyridine Calcium Channel Blocker, HMG-CoA Reductase Inhibitor, Poly(ADP-Ribose) Polymerase Inhibitor, Janus Kinase Inhibitor, Calcitonin Gene-related Peptide Receptor Antagonist, General Anesthetic, Blood Coagulation Factor, Recombinant Human Growth Hormone, Erythropoiesis-stimulating Agent, CD20-directed Cytolytic Antibody, Vascular Endothelial Growth Factor Inhibitor, Folate Analog, Sphingosine 1-phosphate Receptor Modulator, Estrogen, Anti-coagulant, Low Molecular Weight Heparin, HER2/neu Receptor Antagonist, Leukocyte Growth Factor
- HCPCS / J-code
- CPT 90678 — Vaccine product code for ABRYSVO (respiratory syncytial virus vaccine, bivalent), J9355 — Injection, trastuzumab, excludes biosimilar, 10 mg, J2506 — Injection, pegfilgrastim, excludes biosimilar, 0.5 mg, J9312 — Injection, rituximab, 10 mg, J9035 — Injection, bevacizumab, 10 mg
- Package NDCs
- 108 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Panzygaimmune globulin intravenous (human) | Human immunoglobulin g 100 mg/mL | SolutionIntravenous | 0069-1011 | 00069-1011-02 | — |
| Panzygaimmune globulin intravenous (human) | Human immunoglobulin g 100 mg/mL | SolutionIntravenous | 0069-1224 | 00069-1224-02 | — |
| Panzygaimmune globulin intravenous (human) | Human immunoglobulin g 100 mg/mL | SolutionIntravenous | 0069-1312 | 00069-1312-02 | — |
| Panzygaimmune globulin intravenous (human) | Human immunoglobulin g 100 mg/mL | SolutionIntravenous | 0069-1109 | 00069-1109-02 | — |
| Panzygaimmune globulin intravenous (human) | Human immunoglobulin g 100 mg/mL | SolutionIntravenous | 0069-1558 | 00069-1558-02 | — |
| Zithromaxazithromycin dihydrate | Azithromycin dihydrate 250 mg/1 | Tablet, Film coatedOral | 0069-4061 | 00069-4061-01 | — |
| Vyndaqeltafamidis meglumine | Tafamidis meglumine 20 mg/1 | Capsule, Liquid filledOral | 0069-1975 | 00069-1975-40 | — |
| Nivestymfilgrastim-aafi | Filgrastim 300 ug/mL | Injection, SolutionIntravenous, Subcutaneous | 0069-0293 | 00069-0293-10 | — |
| Nivestymfilgrastim-aafi | Filgrastim 480 ug/1.6mL | Injection, SolutionIntravenous, Subcutaneous | 0069-0294 | 00069-0294-10 | — |
| Daurismoglasdegib | Glasdegib 100 mg/1 | Tablet, Film coatedOral | 0069-1531 | 00069-1531-30 | — |
| Daurismoglasdegib | Glasdegib 25 mg/1 | Tablet, Film coatedOral | 0069-0298 | 00069-0298-60 | — |
| Lorbrenalorlatinib | Lorlatinib 100 mg/1 | Tablet, Film coatedOral | 0069-0231 | 00069-0231-01 | — |
| Lorbrenalorlatinib | Lorlatinib 25 mg/1 | Tablet, Film coatedOral | 0069-0227 | 00069-0227-0100069-0227-03 | — |
| Talzennatalazoparib | Talazoparib tosylate .25 mg/1 | CapsuleOral | 0069-0296 | 00069-0296-30 | — |
| Talzennatalazoparib | Talazoparib tosylate 1 mg/1 | CapsuleOral | 0069-1195 | 00069-1195-30 | — |
| Vizimprodacomitinib | Dacomitinib 30 mg/1 | Tablet, Film coatedOral | 0069-1198 | 00069-1198-30 | — |
| Vizimprodacomitinib | Dacomitinib 45 mg/1 | Tablet, Film coatedOral | 0069-2299 | 00069-2299-30 | — |
| Vizimprodacomitinib | Dacomitinib 15 mg/1 | Tablet, Film coatedOral | 0069-0197 | 00069-0197-30 | — |
| Nivestymfilgrastim-aafi | Filgrastim 300 ug/.5mL | Injection, SolutionSubcutaneous | 0069-0291 | 00069-0291-0100069-0291-10 | — |
| Nivestymfilgrastim-aafi | Filgrastim 480 ug/.8mL | Injection, SolutionSubcutaneous | 0069-0292 | 00069-0292-0100069-0292-10 | — |
| Xeljanztofacitinib | Tofacitinib citrate 10 mg/1 | Tablet, Film coatedOral | 0069-1002 | 00069-1002-01 | — |
| Retacritepoetin alfa-epbx | Epoetin 10000 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | 0069-1308 | 00069-1308-10 | — |
| Retacritepoetin alfa-epbx | Epoetin 3000 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | 0069-1306 | 00069-1306-10 | — |
| Retacritepoetin alfa-epbx | Epoetin 40000 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | 0069-1309 | 00069-1309-04 | — |
| Retacritepoetin alfa-epbx | Epoetin 4000 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | 0069-1307 | 00069-1307-10 | — |
| Retacritepoetin alfa-epbx | Epoetin 2000 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | 0069-1305 | 00069-1305-10 | — |
| Bosulifbosutinib | Bosutinib monohydrate 400 mg/1 | Tablet, Film coatedOral | 0069-0193 | 00069-0193-01 | — |
| Eucrisacrisaborole | Crisaborole 20 mg/g | OintmentTopical | 55724-211 | 55724-0211-1155724-0211-2155724-0211-23+1 more | — |
| Inflectrainfliximab-dyyb | Infliximab 100 mg/10mL | Injection, Powder, Lyophilized, For solutionIntravenous | 0069-0809 | 00069-0809-01 | J1745 |
| Xeljanz XRtofacitinib | Tofacitinib citrate 11 mg/1 | Tablet, Film coated, Extended releaseOral | 0069-0501 | 00069-0501-30 | — |
| Fragmindalteparin sodium | Dalteparin sodium 2500 [iU]/.2mL | InjectionSubcutaneous | 0069-0195 | 00069-0195-02 | — |
| Fragmindalteparin sodium | Dalteparin sodium 15000 [iU]/.6mL | InjectionSubcutaneous | 0069-0223 | 00069-0223-02 | — |
| Fragmindalteparin sodium | Dalteparin sodium 10000 [iU]/mL | InjectionSubcutaneous | 0069-0217 | 00069-0217-02 | — |
| Fragmindalteparin sodium | Dalteparin sodium 7500 [iU]/.3mL | InjectionSubcutaneous | 0069-0206 | 00069-0206-02 | — |
| Fragmindalteparin sodium | Dalteparin sodium 5000 [iU]/.2mL | InjectionSubcutaneous | 0069-0196 | 00069-0196-02 | — |
| Fragmindalteparin sodium | Dalteparin sodium 12500 [iU]/.5mL | InjectionSubcutaneous | 0069-0220 | 00069-0220-02 | — |
| Fragmindalteparin sodium | Dalteparin sodium 25000 [iU]/mL | InjectionSubcutaneous | 0069-0232 | 00069-0232-01 | — |
| Fragmindalteparin sodium | Dalteparin sodium 18000 [iU]/.72mL | InjectionSubcutaneous | 0069-0228 | 00069-0228-02 | — |
| Ibrancepalbociclib | Palbociclib 125 mg/1 | CapsuleOral | 0069-0189 | 00069-0189-21 | — |
| Ibrancepalbociclib | Palbociclib 75 mg/1 | CapsuleOral | 0069-0187 | 00069-0187-21 | — |
| Ibrancepalbociclib | Palbociclib 100 mg/1 | CapsuleOral | 0069-0188 | 00069-0188-21 | — |
| Sutentsunitinib malate | Sunitinib malate 37.5 mg/1 | CapsuleOral | 0069-0830 | 00069-0830-38 | — |
| Zithromaxazithromycin dihydrate | Azithromycin dihydrate 500 mg/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | 0069-0400 | 00069-0400-10 | — |
| Cerebyxfosphenytoin sodium | Fosphenytoin sodium 50 mg/mL | Injection, SolutionIntramuscular, Intravenous | 0069-5471 | 00069-5471-02 | — |
| Cerebyxfosphenytoin sodium | Fosphenytoin sodium 50 mg/mL | Injection, SolutionIntramuscular, Intravenous | 0069-6001 | 00069-6001-2100069-6001-25 | — |
| Cerebyxfosphenytoin sodium | Fosphenytoin sodium 50 mg/mL | Injection, SolutionIntramuscular, Intravenous | 0069-5474 | 00069-5474-02 | — |
| Xeljanztofacitinib | Tofacitinib citrate 5 mg/1 | Tablet, Film coatedOral | 0069-1001 | 00069-1001-01 | — |
| Bosulifbosutinib | Bosutinib monohydrate 500 mg/1 | Tablet, Film coatedOral | 0069-0136 | 00069-0136-01 | — |
| Bosulifbosutinib | Bosutinib monohydrate 100 mg/1 | Tablet, Film coatedOral | 0069-0135 | 00069-0135-01 | — |
| Elelysotaliglucerase alfa | Taliglucerase alfa 200 U/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | 0069-0106 | 00069-0106-01 | — |
Pfizer Laboratories Div Pfizer Inc: common questions
- What is Pfizer Laboratories Div Pfizer Inc's NDC labeler code?
- 0013, 0025, 0069, 60793, 72618. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Pfizer Laboratories Div Pfizer Inc?
- Med-Code's HCPCS directory matches CPT 90678, J9355, J2506, J9312, J9035 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.